ARCHIVES

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Shannn Award Selections Made; ACS Funds 431 Grants Worth $50 Mil.; 500 Nurses Pass Exam

August 30, 1991

Clinical Trials Approved By NCI

March 26, 2004

DCT Concepts Approved

October 11, 1985

Obituaries: Jessie Gruman, 60, CFAH Founder and President; Jesse Leonard Steinfeld, 87, U.S. Surgeon General

September 5, 2014

NCI to Undergo More GAO Probes

July 15, 1977

Howard Temin, 59, NCAB Member, Nobel Laureate, Dead

February 18, 1994